CCI initiates investigation against Max Super Specialty Hospitals for alleged abuse of dominance* The CCI in its order dated November 17,
The Indian Competition Authority opens investigation into abuse of dominance by syringe manufacturer and a group of hospitals (Vivek Sharma / Becton Dickinson India / Max Super Speciality Hospital)
Access to this article is restricted to subscribers
Already Subscribed? Sign-in
Access to this article is restricted to subscribers.
Read one article for free
Sign-up to read this article for free and discover our services.